Effectiveness of Cannabis in the Treatment of Tinnitus Patients

Phase 1

Withdrawn

• Conditions: Tinnitus
• Interventions: Drug: Cannabis; Drug: Placebo

• Registration Number: NCT01969474
• Lead Sponsor: Wolfson Medical Center

Brief Summary

The hypothesis of the study is that the use of Cannabis will attenuate the tinnitus level as experienced by the patients.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2013-10-14
• Study First Submitted QC: 2013-10-21
• Study First Posted: 2013-10-25
• Study Start: 2013-12
• Status Verified: 2016-12
• Primary Completion: 2016-12
• Last Update Submitted: 2016-12-25
• Last Update Posted: 2016-12-28

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Tinnitus lasting more than 3 months
• Tinnitus Handicap Inventory score over 58
• Treated previously for tinnitus (2 modalities)

Exclusion Criteria

• Prior use of drugs
• Current use of Cannabis
• Neurologic or Psychiatric disease
• Heart Failure
• Ischemic Heart Disease
• Immune Deficiency
• Acoustic Neuroma

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Cannabis	Cannabis	Treatment with a Cannabis capsule
Placebo	Placebo	Placebo

Primary Outcome Measures

Name	Time	Method
Tinnitus handicap inventory score	2 months	Patients will be monitored during a month (treatment time) and a month later

Trial Locations

Locations (1)

Wolfson Medical Centre; 🇮🇱 Holon, Israel